{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:09:09Z","timestamp":1768518549634,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["KY103RC180003"],"award-info":[{"award-number":["KY103RC180003"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01931-y","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:59:42Z","timestamp":1752505182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors"],"prefix":"10.1186","volume":"17","author":[{"given":"Wenkang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuandong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"1931_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344.","journal-title":"Lancet"},{"key":"1931_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/cancers15010243","volume":"15","author":"T Ying","year":"2022","unstructured":"Ying T, Wang X, Yao Y, Yuan J, Chen S, Wen L, Chen Z, Wang X, Luo C, Sheng J, Wang W, Teng L. Integrative methylome and transcriptome characterization identifies SERINC2 as a tumor-driven gene for papillary thyroid carcinoma. Cancers. 2022;15:243.","journal-title":"Cancers"},{"key":"1931_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41574-019-0263-x","volume":"16","author":"J Kim","year":"2020","unstructured":"Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16:17\u201329.","journal-title":"Nat Rev Endocrinol"},{"key":"1931_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12020-020-02207-6","volume":"68","author":"J Wang","year":"2020","unstructured":"Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid cancer: incidence and mortality trends in China, 2005\u20132015. Endocrine. 2020;68:163\u201373.","journal-title":"Endocrine"},{"key":"1931_CR5","unstructured":"F. B, M. C, L. M, M. P, A. Z, R. Z, J. F, Cancer incidence in five continents, 2017."},{"key":"1931_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00330-022-09126-2","volume":"33","author":"K Lu","year":"2023","unstructured":"Lu K, Wang L, Lai S, Chen Z, Cong S, Huang C, Gan K, Guan H, Kuang J. A new discriminant strategy combined with four TIRADS screening procedures increases ultrasound diagnostic accuracy-focusing on \u201cwrong diagnostic\u201d thyroid nodules. Eur Radiol. 2023;33:784\u201396.","journal-title":"Eur Radiol"},{"key":"1931_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-8587(22)00101-2","volume":"10","author":"EK Alexander","year":"2022","unstructured":"Alexander EK, Cibas ES. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 2022;10:533\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"1931_CR8","first-page":"1039","volume":"33","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for reporting thyroid cytopathology. Thyroid. 2023;33(9):1039\u201344.","journal-title":"Thyroid"},{"key":"1931_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1309\/AJCPPHLWMI3JV4LA","volume":"132","author":"ES Cibas","year":"2009","unstructured":"Cibas ES, Ali SZ. The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658\u201365.","journal-title":"Am J Clin Pathol"},{"key":"1931_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241597","volume":"15","author":"HY Na","year":"2020","unstructured":"Na HY, Moon JH, Choi JY, Yu HW, Jeong WJ, Kim YK, Choe JY, Park SY. Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: analysis of cause of under- or misdiagnoses. PLoS ONE. 2020;15: e0241597.","journal-title":"PLoS ONE"},{"key":"1931_CR11","first-page":"Cd012483","volume":"1","author":"R Cirocchi","year":"2019","unstructured":"Cirocchi R, Arezzo A, D\u2019Andrea V, Abraha I, Popivanov GI, Avenia N, Gerardi C, Henry BM, Randolph J, Barczy\u00f1ski M. Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery. Cochrane Database Syst Rev. 2019;1:Cd012483.","journal-title":"Cochrane Database Syst Rev"},{"key":"1931_CR12","first-page":"81","volume":"59","author":"J Lukinovi\u0107","year":"2020","unstructured":"Lukinovi\u0107 J, Bili\u0107 M. Overview of thyroid surgery complications. Acta Clin Croat. 2020;59:81\u20136.","journal-title":"Acta Clin Croat"},{"key":"1931_CR13","first-page":"38","volume":"23","author":"XT Yu","year":"2025","unstructured":"Yu XT, Li JX. Research on deep learning-based auxiliary diagnosis method for lung cancer (in Chinese). J Digit Manufact Sci. 2025;23:38\u201342.","journal-title":"J Digit Manufact Sci"},{"key":"1931_CR14","first-page":"985","volume":"52","author":"YF Yang","year":"2023","unstructured":"Yang YF, Wu SF, Li Y, Nie X, Guo LC, Xi YF, Li ZS, Liu YP, Teng LH, He C, Su D, Zhao YW, et al. A survey report on personnel, equipment, and workload in Chinese pathology departments during 2019\u20132020 (in Chinese). Chin J Pathol. 2023;52:985\u20138.","journal-title":"Chin J Pathol"},{"key":"1931_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4337","volume":"2","author":"DM Metter","year":"2019","unstructured":"Metter DM, Colgan TJ, Leung ST, Timmons CF, Park JY. Trends in the US and Canadian pathologist workforces from 2007 to 2017. JAMA Netw Open. 2019;2: e194337.","journal-title":"JAMA Netw Open"},{"key":"1931_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2213-8587(21)00083-8","volume":"9","author":"M Li","year":"2021","unstructured":"Li M, Zheng R, Dal Maso L, Zhang S, Wei W, Vaccarella S. Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol. 2021;9:330\u20132.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1931_CR17","first-page":"1219","volume":"43","author":"M Jinih","year":"2017","unstructured":"Jinih M, Foley N, Osho O, Houlihan L, Toor AA, Khan JZ, Achakzai AA, Redmond HP. BRAF(V600E) mutation as a predictor of thyroid malignancy in indeterminate nodules: a systematic review and meta-analysis. Euro J Surg Oncol J Euro Soc Surg Oncol British Assoc of Surg Oncol. 2017;43:1219\u201327.","journal-title":"Euro J Surg Oncol J Euro Soc Surg Oncol British Assoc of Surg Oncol"},{"key":"1931_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.humpath.2015.06.001","volume":"46","author":"N Fnais","year":"2015","unstructured":"Fnais N, Soobiah C, Al-Qahtani K, Hamid JS, Perrier L, Straus SE, Tricco AC. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis. Hum Pathol. 2015;46:1443\u201354.","journal-title":"Hum Pathol"},{"key":"1931_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569\u201380.","journal-title":"Nat Rev Endocrinol"},{"key":"1931_CR20","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-15-0533","volume":"23","author":"R Liu","year":"2016","unstructured":"Liu R, Xing M. TERT promoter mutations in thyroid cancer. Endocr Relat Cancer. 2016;23:R143\u201355.","journal-title":"Endocr Relat Cancer"},{"key":"1931_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Medullary thyroid cancer: management guidelines of the American thyroid association. Thyroid Off J Am Thyr Assoc. 2009;19:565\u2013612.","journal-title":"Thyroid Off J Am Thyr Assoc"},{"key":"1931_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/ERC-16-0512","volume":"24","author":"P Valderrabano","year":"2017","unstructured":"Valderrabano P, Khazai L, Leon ME, Thompson ZJ, Ma Z, Chung CH, Hallanger-Johnson JE, Otto KJ, Rogers KD, Centeno BA, McIver B. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Endocr Relat Cancer. 2017;24:127\u201336.","journal-title":"Endocr Relat Cancer"},{"key":"1931_CR23","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18801","volume":"13","author":"MLG de Matos","year":"2025","unstructured":"de Matos MLG, Pinto M, Gon\u00e7alves A, Canberk S, Bugalho MJM, Soares P. Insights in biomarkers complexity and routine clinical practice for the diagnosis of thyroid nodules and cancer. PeerJ. 2025;13: e18801.","journal-title":"PeerJ"},{"key":"1931_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/EJE-11-0499","volume":"165","author":"V Marotta","year":"2011","unstructured":"Marotta V, Guerra A, Sapio MR, Vitale M. RET\/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol. 2011;165:499\u2013507.","journal-title":"Eur J Endocrinol"},{"key":"1931_CR25","doi-asserted-by":"publisher","first-page":"1113977","DOI":"10.3389\/fendo.2023.1113977","volume":"14","author":"N Uppal","year":"2023","unstructured":"Uppal N, Collins R, James B. Thyroid nodules: global, economic, and personal burdens. Front Endocrinol. 2023;14:1113977.","journal-title":"Front Endocrinol"},{"key":"1931_CR26","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1210\/clinem\/dgaa322","volume":"105","author":"G Grani","year":"2020","unstructured":"Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. J Clin Endocrinol Metab. 2020;105:2869\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1931_CR27","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/med.21696","volume":"40","author":"A Liu","year":"2020","unstructured":"Liu A, Wu Q, Peng D, Ares I, Anad\u00f3n A, Lopez-Torres B, Mart\u00ednez-Larra\u00f1aga MR, Wang X, Mart\u00ednez MA. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Med Res Rev. 2020;40:1973\u20132018.","journal-title":"Med Res Rev"},{"key":"1931_CR28","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1089\/thy.2018.0458","volume":"29","author":"MC Barros-Filho","year":"2019","unstructured":"Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andrade VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR. DNA methylation-based method to differentiate malignant from benign thyroid lesions. Thyr Off J Am Thyr Assoc. 2019;29:1244\u201354.","journal-title":"Thyr Off J Am Thyr Assoc"},{"key":"1931_CR29","doi-asserted-by":"publisher","first-page":"R415","DOI":"10.1530\/ERC-19-0093","volume":"26","author":"C Zafon","year":"2019","unstructured":"Zafon C, Gil J, P\u00e9rez-Gonz\u00e1lez B, Jord\u00e0 M. DNA methylation in thyroid cancer. Endocr Relat Cancer. 2019;26:R415\u201339.","journal-title":"Endocr Relat Cancer"},{"key":"1931_CR30","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1016\/j.cell.2023.06.022","volume":"186","author":"GJ Rahme","year":"2023","unstructured":"Rahme GJ, Javed NM, Puorro KL, Xin S, Hovestadt V, Johnstone SE, Bernstein BE. Modeling epigenetic lesions that cause gliomas. Cell. 2023;186:3674-85.e14.","journal-title":"Cell"},{"key":"1931_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-024-07328-w","volume":"629","author":"V Parreno","year":"2024","unstructured":"Parreno V, Loubiere V, Schuettengruber B, Fritsch L, Rawal CC, Erokhin M, Gy\u0151rffy B, Normanno D, Di Stefano M, Moreaux J, Butova NL, Chiolo I, et al. Transient loss of Polycomb components induces an epigenetic cancer fate. Nature. 2024;629:688\u201396.","journal-title":"Nature"},{"key":"1931_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/thy.2019.0011","volume":"30","author":"JL Park","year":"2020","unstructured":"Park JL, Jeon S, Seo EH, Bae DH, Jeong YM, Kim Y, Bae JS, Kim SK, Jung CK, Kim YS. Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer. Thyr Off J Am Thyr Assoc. 2020;30:192\u2013203.","journal-title":"Thyr Off J Am Thyr Assoc"},{"key":"1931_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.736068","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao Y, Xu P, Ying T, Wang Y, Wang X, Shu L, Mo Z, Chen Z, Wang X, Wang W, Teng L, Lou X. Integrative analysis of DNA methylation and gene expression identified follicular thyroid cancer-specific diagnostic biomarkers. Front Endocrinol. 2021;12: 736068.","journal-title":"Front Endocrinol"},{"key":"1931_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaac.2018.09.425","volume":"58","author":"OR Phillips","year":"2019","unstructured":"Phillips OR, Onopa AK, Hsu V, Ollila HM, Hillary RP, Hallmayer J, Gotlib IH, Taylor J, Mackey L, Singh MK. Beyond a binary classification of sex: an examination of brain sex differentiation, psychopathology, and genotype. J Am Acad Child Adolesc Psychiatry. 2019;58:787\u201398.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1931_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0960-9822(09)00453-9","volume":"6","author":"RH Insall","year":"1996","unstructured":"Insall RH, Borleis J, Devreotes PN. The aimless RasGEF is required for processing of chemotactic signals through G-protein-coupled receptors in Dictyostelium. Current biology\u202f: CB. 1996;6:719\u201329.","journal-title":"Current biology : CB"},{"key":"1931_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","volume":"129","author":"JL Bos","year":"2007","unstructured":"Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell. 2007;129:865\u201377.","journal-title":"Cell"},{"key":"1931_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1158\/1535-7163.MCT-06-0659","volume":"6","author":"C Suzuki","year":"2007","unstructured":"Suzuki C, Takahashi K, Hayama S, Ishikawa N, Kato T, Ito T, Tsuchiya E, Nakamura Y, Daigo Y. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol Cancer Ther. 2007;6:542\u201351.","journal-title":"Mol Cancer Ther"},{"key":"1931_CR38","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s13402-023-00814-9","volume":"46","author":"Z Guo","year":"2023","unstructured":"Guo Z, Xie Q, Wu Y, Mo H, Zhang J, He G, Li Z, Gan L, Feng L, Li T, Wang Y, Fu Y, et al. Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B\/RAS\/MAPK axis in hepatocellular carcinoma. Cell Oncol (Dordr). 2023;46:1333\u201350.","journal-title":"Cell Oncol (Dordr)"},{"key":"1931_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.743840","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Lin Z, Liu Q, Chen S, Gao X, Guo W, Gong F, Wei J, Lin H. Enhancer RNA SLIT2 inhibits bone metastasis of breast cancer through regulating P38 MAPK\/c-Fos signaling pathway. Front Oncol. 2021;11: 743840.","journal-title":"Front Oncol"},{"key":"1931_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/14728222.2011.645805","volume":"16","author":"L Santarpia","year":"2012","unstructured":"Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:103\u201319.","journal-title":"Expert Opin Ther Targets"},{"key":"1931_CR41","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.3390\/cells10092430","volume":"10","author":"NI Yang","year":"2021","unstructured":"Yang NI, Yeh CH, Tsai TH, Chou YJ, Hsu PW, Li CH, Chan YH, Kuo LT, Mao CT, Shyu YC, Hung MJ, Lai CC, et al. Artificial intelligence-assisted identification of genetic factors predisposing high-risk individuals to asymptomatic heart failure. Cells. 2021;10:2430.","journal-title":"Cells"},{"key":"1931_CR42","doi-asserted-by":"publisher","first-page":"19235","DOI":"10.1038\/s41598-021-98725-y","volume":"11","author":"Z Jafarian","year":"2021","unstructured":"Jafarian Z, Khamse S, Afshar H, Khorshid HRK, Delbari A, Ohadi M. Natural selection at the RASGEF1C (GGC) repeat in human and divergent genotypes in late-onset neurocognitive disorder. Sci Rep. 2021;11:19235.","journal-title":"Sci Rep"},{"key":"1931_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/cells11040731","volume":"11","author":"A Prell","year":"2022","unstructured":"Prell A, Sen MO, Potabattula R, Bernhardt L, Dittrich M, Hahn T, Schorsch M, Zacchini F, Ptak GE, Niemann H, Haaf T. Species-specific paternal age effects and sperm methylation levels of developmentally important genes. Cells. 2022;11:731.","journal-title":"Cells"},{"key":"1931_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S2213-8587(22)00139-5","volume":"10","author":"EK Alexander","year":"2022","unstructured":"Alexander EK, Doherty GM, Barletta JA. Management of thyroid nodules. Lancet Diabetes Endocrinol. 2022;10:540\u20138.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1931_CR45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12859-016-1347-4","volume":"17","author":"L Weinhold","year":"2016","unstructured":"Weinhold L, Wahl S, Pechlivanis S, Hoffmann P, Schmid M. A statistical model for the analysis of beta values in DNA methylation studies. BMC Bioinform. 2016;17:480.","journal-title":"BMC Bioinform"},{"key":"1931_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(18)31268-6","volume":"392","author":"Y Dor","year":"2018","unstructured":"Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet. 2018;392:777\u201386.","journal-title":"Lancet"},{"key":"1931_CR47","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1111\/j.1742-4658.2009.07166.x","volume":"276","author":"E Yaman","year":"2009","unstructured":"Yaman E, Gasper R, Koerner C, Wittinghofer A, Tazebay UH. RasGEF1A and RasGEF1B are guanine nucleotide exchange factors that discriminate between Rap GTP-binding proteins and mediate Rap2-specific nucleotide exchange. FEBS J. 2009;276:4607\u201316.","journal-title":"FEBS J"},{"key":"1931_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057903","volume":"8","author":"WJ Pannekoek","year":"2013","unstructured":"Pannekoek WJ, Linnemann JR, Brouwer PM, Bos JL, Rehmann H. Rap1 and Rap2 antagonistically control endothelial barrier resistance. PLoS ONE. 2013;8: e57903.","journal-title":"PLoS ONE"},{"key":"1931_CR49","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1128\/MCB.20.16.6074-6083.2000","volume":"20","author":"Y Ohba","year":"2000","unstructured":"Ohba Y, Mochizuki N, Matsuo K, Yamashita S, Nakaya M, Hashimoto Y, Hamaguchi M, Kurata T, Nagashima K, Matsuda M. Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol. 2000;20:6074\u201383.","journal-title":"Mol Cell Biol"},{"key":"1931_CR50","doi-asserted-by":"publisher","first-page":"e202107114","DOI":"10.1083\/jcb.202107114","volume":"221","author":"ED Duncan","year":"2022","unstructured":"Duncan ED, Han KJ, Trout MA, Prekeris R. Ubiquitylation by Rab40b\/Cul5 regulates Rap2 localization and activity during cell migration. J Cell Biol. 2022;221:e202107114.","journal-title":"J Cell Biol"},{"key":"1931_CR51","doi-asserted-by":"publisher","first-page":"e202203029","DOI":"10.1083\/jcb.202203029","volume":"221","author":"PT Caswell","year":"2022","unstructured":"Caswell PT. Non-canonical ubiquitylation makes its mark on Rap2 and cell motility. J Cell Biol. 2022;221:e202203029.","journal-title":"J Cell Biol"},{"key":"1931_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1530\/ERC-12-0086","volume":"19","author":"X Dong","year":"2012","unstructured":"Dong X, Tang W, Stopenski S, Brose MS, Korch C, Meinkoth JL. RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells. Endocr Relat Cancer. 2012;19:575\u201388.","journal-title":"Endocr Relat Cancer"},{"key":"1931_CR53","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.emboj.7600571","volume":"24","author":"SC Choi","year":"2005","unstructured":"Choi SC, Han JK. Rap2 is required for Wnt\/beta-catenin signaling pathway in Xenopus early development. EMBO J. 2005;24:985\u201396.","journal-title":"EMBO J"},{"key":"1931_CR54","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1038\/sj.emboj.7601781","volume":"26","author":"RH Lee","year":"2007","unstructured":"Lee RH, Iioka H, Ohashi M, Iemura S, Natsume T, Kinoshita N. XRab40 and XCullin5 form a ubiquitin ligase complex essential for the noncanonical Wnt pathway. EMBO J. 2007;26:3592\u2013606.","journal-title":"EMBO J"},{"key":"1931_CR55","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbrc.2013.05.104","volume":"436","author":"DS Park","year":"2013","unstructured":"Park DS, Seo JH, Hong M, Choi SC. Role of the Rap2\/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling. Biochem Biophys Res Commun. 2013;436:338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"1931_CR56","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.7150\/thno.66142","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ruan X, Li Y, Zhi J, Hu L, Hou X, Shi X, Wang X, Wang J, Ma W, Gu P, Zheng X, et al. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt\/\u03b2-catenin signaling pathway. Theranostics. 2022;12:1500\u201317.","journal-title":"Theranostics"},{"key":"1931_CR57","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1038\/s41388-022-02359-x","volume":"41","author":"X Pan","year":"2022","unstructured":"Pan X, Li X, Sun J, Xiong Z, Hu H, Ning S, Zhi H. Enhancer methylation dynamics drive core transcriptional regulatory circuitry in pan-cancer. Oncogene. 2022;41:3474\u201384.","journal-title":"Oncogene"},{"key":"1931_CR58","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, Xia C, Sun K, Yang Z, Li H, Wang N, Han R, et al. Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555\u201367.","journal-title":"Lancet Glob Health"},{"key":"1931_CR59","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.3390\/ijms222312992","volume":"22","author":"V Suteau","year":"2021","unstructured":"Suteau V, Munier M, Briet C, Rodien P. Sex bias in differentiated thyroid cancer. Int J Mol Sci. 2021;22:12992.","journal-title":"Int J Mol Sci"},{"key":"1931_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.pharmthera.2018.11.001","volume":"195","author":"A Unnikrishnan","year":"2019","unstructured":"Unnikrishnan A, Freeman WM, Jackson J, Wren JD, Porter H, Richardson A. The role of DNA methylation in epigenetics of aging. Pharmacol Ther. 2019;195:172\u201385.","journal-title":"Pharmacol Ther"},{"key":"1931_CR61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19:371\u201384.","journal-title":"Nat Rev Genet"},{"key":"1931_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006767","volume":"4","author":"MP Boks","year":"2009","unstructured":"Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, Kahn RS, Ophoff RA. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS ONE. 2009;4: e6767.","journal-title":"PLoS ONE"},{"key":"1931_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109541","volume":"68","author":"N Miningou","year":"2020","unstructured":"Miningou N, Blackwell KT. The road to ERK activation: Do neurons take alternate routes? Cell Signal. 2020;68: 109541.","journal-title":"Cell Signal"},{"key":"1931_CR64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2015.07.011","volume":"58","author":"RP Waters","year":"2015","unstructured":"Waters RP, Rivalan M, Bangasser DA, Deussing JM, Ising M, Wood SK, Holsboer F, Summers CH. Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci Biobehav Rev. 2015;58:63\u201378.","journal-title":"Neurosci Biobehav Rev"},{"key":"1931_CR65","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.3390\/ijms22115744","volume":"22","author":"E Bonaldi","year":"2021","unstructured":"Bonaldi E, Gargiuli C, De Cecco L, Micali A, Rizzetti MG, Greco A, Borrello MG, Minna E. BRAF inhibitors induce feedback activation of RAS pathway in thyroid cancer cells. Int J Mol Sci. 2021;22:5744.","journal-title":"Int J Mol Sci"},{"key":"1931_CR66","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1210\/jc.2005-0987","volume":"90","author":"M Xing","year":"2005","unstructured":"Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005;90:6373\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1931_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","volume":"33","author":"M Xing","year":"2015","unstructured":"Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, Elisei R, Bendlov\u00e1 B, Yip L, Mian C, Vianello F, Tuttle RM, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:42\u201350.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1931_CR68","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jama.2013.3190","volume":"309","author":"M Xing","year":"2013","unstructured":"Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA. 2013;309:1493\u2013501.","journal-title":"JAMA"},{"key":"1931_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, D\u2019Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A. Hashimoto\u2019s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19: 102649.","journal-title":"Autoimmun Rev"},{"key":"1931_CR70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2017.00053","volume":"7","author":"C Resende de Paiva","year":"2017","unstructured":"Resende de Paiva C, Gr\u00f8nh\u00f8j C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto\u2019s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. 2017;7:53.","journal-title":"Front Oncol"},{"key":"1931_CR71","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/thy.2019.0347","volume":"30","author":"RD Paparodis","year":"2020","unstructured":"Paparodis RD, Karvounis E, Bantouna D, Chourpiliadis C, Chourpiliadi H, Livadas S, Imam S, Jaume JC. Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular Goiter or Graves\u2019 disease. Thyr Off J Am Thyr Assoc. 2020;30:531\u20135.","journal-title":"Thyr Off J Am Thyr Assoc"},{"key":"1931_CR72","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11154-018-9474-z","volume":"19","author":"R Vita","year":"2018","unstructured":"Vita R, Ieni A, Tuccari G, Benvenga S. The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma. Rev Endocr Metab Disord. 2018;19:301\u20139.","journal-title":"Rev Endocr Metab Disord"},{"key":"1931_CR73","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"key":"1931_CR74","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MED.0000000000000570","volume":"27","author":"U Feldt-Rasmussen","year":"2020","unstructured":"Feldt-Rasmussen U. Hashimoto\u2019s thyroiditis as a risk factor for thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2020;27:364\u201371.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1931_CR75","first-page":"396","volume":"8","author":"B Wang","year":"2017","unstructured":"Wang B, Shao X, Song R, Xu D, Zhang JA. The emerging role of epigenetics in autoimmune thyroid diseases. Front Immunol. 2017;8:396.","journal-title":"Front Immunol"},{"key":"1931_CR76","doi-asserted-by":"publisher","first-page":"1020709","DOI":"10.3389\/fpubh.2022.1020709","volume":"10","author":"X Hu","year":"2022","unstructured":"Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto\u2019s thyroiditis in adults: a systematic review and meta-analysis. Front Public Health. 2022;10:1020709.","journal-title":"Front Public Health"},{"key":"1931_CR77","doi-asserted-by":"publisher","first-page":"1029926","DOI":"10.3389\/fonc.2022.1029926","volume":"12","author":"C Mu","year":"2022","unstructured":"Mu C, Ming X, Tian Y, Liu Y, Yao M, Ni Y, Liu Y, Li Z. Mapping global epidemiology of thyroid nodules among general population: a systematic review and meta-analysis. Front Oncol. 2022;12:1029926.","journal-title":"Front Oncol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01931-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01931-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:37:43Z","timestamp":1757241463000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01931-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01931-y","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the ethic committee of Nanjing Medical University ((2020) 528). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}